In partnership with CMS, NQF will convene a multistakeholder Committee of experts to oversee the development of a measurement framework that addresses polysubstance use involving synthetic or semi-synthetic opioids (SSSO) among individuals with co-occurring Behavioral Health (BH) conditions. This activity will further identify measure gaps and priorities relevant to the United States opioid overdose epidemic and the broad healthcare quality challenges that surround it. Read more